JC virus detection and JC virus-specific immunity in natalizumab-treated Multiple Sclerosis patients
<p>Abstract</p> <p>Background</p> <p>The use of natalizumab in multiple sclerosis (MS) may favour JC virus reactivation; this phenomenon is usually asymptomatic but can, albeit rarely, evolve into frank progressive multifocal leucoencephalopathy (PML).</p> <p>Methods</p> <p>JCV-specific CD8+ T lymph...
Uloženo v:
| Hlavní autoři: | , , , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BMC
2012-12-01
|
| Edice: | Journal of Translational Medicine |
| Témata: | |
| On-line přístup: | http://www.translational-medicine.com/content/10/1/248 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
